Search Within

Alan M Hanash

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Meeting Abstract (44)
  2. Journal Article (28)
  3. Editorial (1)
Groups
  1. Bone Marrow Transplant (73)
  2. Center for Hematologic Malignancies (73)
  3. Department of Medicine (73)
  4. GSK Faculty (73)
  5. Hematologic Malignancies, Division of (73)
  6. Human Oncology and Pathogenesis Program (73)

More Groups

People
  1. Marcel Van Den Brink (47)
  2. Odette Smith (30)
  3. Robert Jenq (27)
  4. Jennifer Tsai (25)
  5. Jarrod Dudakov (24)
  6. Marco Calafiore (24)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (5)
  4. 2022 (6)
  5. 2021 (1)
  6. 2020 (5)

More Years

Publications
  1. Blood (25)
  2. Biology of Blood and Marrow Transplantation (15)
  3. Immunity (4)
  4. Journal of Immunology (4)
  5. Journal of Clinical Investigation (3)
  6. Nature Medicine (3)

More Publications

Publishers
  1. American Society of Hematology (25)
  2. Elsevier Inc. (18)
  3. Nature Publishing Group (9)
  4. American Association for the Advancement of Science (4)
  5. Cell Press (4)
  6. The American Association of Immunologists, Inc (4)

More Publishers

Results (73)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Suppression of luteinizing hormone enhances HSC recovery after hematopoietic injuries
    Meeting Abstract

    Velardi, E.; Tsai, J. J. Y.; Argyropoulos, K. V.; Jae-Hung, S.; Lieberman, S.; Kreines, F.; Shono, Y.; Young, L.; Wertheimer, T.; Jenq, R. R.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • TP53 mutations in AML predict adverse outcome in patients undergoing allogeneic hematopoietic stem cell transplant
    Meeting Abstract

    Getta, B. M.; Ghosh, A.; Coombs, C. C.; Devlin, S.; Arcila, M.; Mohanty, A.; Levine, R. L.; Tallman, M. S.; Jakubowski, A. A.; Giralt, S. A.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice
    Journal Article

    Shono, Y.; Docampo, M. D.; Peled, J. U.; Perobelli, S. M.; Velardi, E.; Tsai, J. J.; Slingerland, A. E.; Smith, O. M.; Young, L. F.; Gupta, J.; more...
    Science Translational Medicine (2016)

    Fulltext@MSK | Save
  • Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease
    Journal Article

    Mathewson, N. D.; Jenq, R.; Mathew, A. V.; Koenigsknecht, M.; Hanash, A.; Toubai, T.; Oravecz-Wilson, K.; Wu, S. R.; Sun, Y. P.; Rossi, C.; more...
    Nature Immunology (2016)

    Fulltext@MSK | Save
  • Interleukin-22 treatment promotes intestinal stem cell mediated epithelial regeneration via Stat3 activation and reduces GI GVHD
    Meeting Abstract

    Lindemans, C. A.; Calafiore, M.; O'Connor, M.; Mertelsmann, A.; van den Brink, M. R. M.; Hanash, A. M.
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • RIG-I-induced Type I IFNs promote regeneration of the intestinal stem cell compartment during acute tissue damage
    Meeting Abstract

    Fischer, J. C.; Bscheider, M.; Eisenkolb, G.; Wintges, A.; Lindemans, C. A.; Heidegger, S.; Monette, S.; Calafiore, M.; Rodriguez, K. A. P.; Lieberman, S.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration
    Journal Article

    Lindemans, C. A.; Calafiore, M.; Mertelsmann, A. M.; O'Connor, M. H.; Dudakov, J. A.; Jenq, R. R.; Velardi, E.; Young, L. F.; Smith, O. M.; Lawrence, G.; more...
    Nature (2015)

    Fulltext@MSK | Save
  • Intestinal Blautia is associated with reduced death from graft-versus-host disease
    Journal Article

    Jenq, R. R.; Taur, Y.; Devlin, S. M.; Ponce, D. M.; Goldberg, J. D.; Ahr, K. F.; Littmann, E. R.; Ling, L.; Gobourne, A. C.; Miller, L. C.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • IL-22 directly regulates intestinal stem cells, protecting epithelium from GVHD and reducing GVHD mortality
    Meeting Abstract

    Lindemans, C. A.; Mertelsmann, A.; O'connor, M.; Calafiore, M.; Dudakov, J. A.; Jenq, R.; Velardi, E.; Young, L.; Smith, O. M.; Lawrence, G.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • IL-22 is an intestinal stem cell growth factor, and IL-22 administration in vivo reduces morbidity and mortality in murine GvHD
    Meeting Abstract

    Lindemans, C. A.; Mertelsmann, A.; O'Connor, M. H.; Dudakov, J. A.; Jenq, R.; Velardi, E.; Young, L. F.; Smith, O. M.; Lawrence, G.; Luo, N.; more...
    Blood (2014)

    Fulltext@MSK | Save